
Nucleate Rhode Island | Inside Clinical Translation: Communication Strategy
Building a successful biotech company requires not just great science but also great communication. Join industry leaders as they discuss what makes a compellin
Building a successful biotech company requires not just great science but also great communication. Join industry leaders as they discuss what makes a compelling narrative, how they navigated the differences between academic and industry communication, and which strategies they have found to be effective in their careers. Panelists Sarah Sutton, PhD - CEO & Founder, Endurance PR Maria Grazia Ruocco, PhD - CEO & Co-Founder, Adelle Diagnostics Isaac Stoner - CEO, MindImmune Therapeutics; Entrepreneur in Residence, Slater Technology Fund About the Host: Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy. We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs! Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma Philanthropic Support: Lyda Hill Philanthropies Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout In-Kind Support: AcademicLabs, Lens.org, SynBioBeta
Independent
From your graph